Kurt G. Calia is a partner in our Palo Alto office practicing in the areas of complex civil litigation, patent litigation, intellectual property, life sciences, and patent prosecution. He is a former co-chair of the firm’s Patent Group, and he currently serves as the Vice Chair for the Trade Secrets Committee of the Intellectual Property Owner’s Association (IPO).
Mr. Calia’s practice focuses largely on the firm’s high technology clients in a wide range of areas including pharmaceutical chemistry, agricultural biotechnology, biomedical devices, nanotechnology, genetics, mechanical devices, business methods, microprocessors, and software.
Mr. Calia has significant trial experience, having appeared as patent trial counsel in the International Trade Commission for Samsung related to light-emitting diodes, for a J&J subsidiary concerning an Alzheimer’s disease drug, and having participated in several intellectual property trials for Monsanto concerning genetically modified crops and herbicides, among other trials.
Mr. Calia also has substantial experience in prosecuting and defending trade secrets cases, particularly arising in the context of complex litigation involving other intellectual property claims.
Mr. Calia has also published and lectured on intellectual property issues, and previously served as an Adjunct Professor at the Howard University Law School where he taught a course on patent enforcement.
- Boston University School of Law, J.D., 1993
- Haverford College, B.S., 1990
Bar Admissions :
- District of Columbia
- U.S. Patent and Trademark Office
Representative Matters :
- Thales Visionix USA, Inc. v. United States (Ct. Fed. Cl. 2014) – Representation of third-party defendant, Elbit Systems of America, LLC, in patent infringement dispute related to helmet mounted display systems used in in the F-35 Joint Strike Fighter.
- Ali v. Carnegie Institution of Washington and University of Massachusetts (D. Ore. 2012) – inventorship dispute related to intellectual property rights to RNA interference.
- In re: Certain Light Emitting Devices, 337-TA-785 (ITC, 2011) – patent infringement matter related to light-emitting diodes.
- In re: ‘318 Patent Infringement Litigation (D. Del. 2005) – patent infringement case involving Alzheimer’s disease drug, Razadyne®.
- Rosemary Ryan-House v. GlaxoSmithKline et al. (E.D. Va. 2003) – patent-antitrust claims related to the antibiotic, Augmentin®.
Pro Bono :
- Representation of the American College of Obstetricians and Gynecologists in constitutional challenges to the Partial Birth Abortion Ban Act of 2003 (U.S. Supreme Court) and Michigan Legal Birth Definition Act (6th Cir.).
- Representation of the Welfare Rights Organizing Coalition in administrative litigation opposing proposed conversion of healthcare organization from non-profit to for-profit status in Washington State and Alaska.
- Representation of D.C. Appleseed in litigation legislation related to healthcare insurance reform.
- Representation of a death row inmate at San Quentin in an excessive use of force and equal protection claim.
Memberships and Affiliations : Mr. Calia currently serves as the Vice Chair of the Trade Secrets Committee of the Intellectual Property Owners Association (IPO).
Rate : $$$$